Maria Sonia S. Salamat

Maria Sonia S. Salamat

Auto-generated profile, based on publicly available information

Maria Sonia S. Salamat

Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Manila, Philippines

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2022 in IJID Regions
Verified
Journal Article
Open access
AMAnna Flor G. Malundo
Anna Flor G. Malundo
CACybele Lara R. Abad
Cybele Lara R. Abad
MSMaria Sonia S. Salamat
Maria Sonia S. Salamat
JSJoanne Carmela M. Sandejas
Joanne Carmela M. Sandejas
JPJose Eladio G. Planta
Jose Eladio G. Planta
MAMarissa M. Alejandria
Marissa M. Alejandria
To describe the clinical profile and outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19) across the spectrum of disease severity. This retrospective study included adult patients with confirmed COVID-19 infection admitted to a referral hospital. Descriptive statistics, tests for trend, Kaplan–Meier curve and log-rank test were used to compare characteristics and outcomes across disease severity categories. Of 1500 patients with COVID-19, 14.8% were asymptomatic, 13.5% had mild disease, 36.6% had moderate disease, 12.3% had severe disease and 22.7% had critical disease. Asymptomatic patients were admitted for a concurrent condition or for isolation. Patients aged >60 years, male gender and with co-morbidities had more severe disease. Fever, cough, shortness of breath, malaise, gastrointestinal symptoms and decreased sensorium were more common in patients with severe disease. Bilateral pulmonary infiltrates were common (51.1%), with sicker patients having more abnormal findings. The overall mortality rate was 15.1%. Adopting a symptom-based strategy reduced the length of hospitalization from a median of 13 [interquartile range (IQR) 7–21] days to 9 (IQR 5–14) days. The clinical profile and outcomes for this cohort of patients with COVID-19 was consistent with published reports. Asymptomatic infection was common, and universal testing may be a valuable strategy in the correct context, given the implications for infection control. A symptom-based strategy was found to reduce the length of hospitalization considerably.

14 July 2022 in IJID Regions
Verified
Journal Article
Open access
AMAnna Flor G. Malundo
Anna Flor G. Malundo
CACybele Lara R. Abad
Cybele Lara R. Abad
MSMaria Sonia S. Salamat
Maria Sonia S. Salamat
JSJoanne Carmela M. Sandejas
Joanne Carmela M. Sandejas
JPJonnel B. Poblete
Jonnel B. Poblete
MAMarissa M. Alejandria
Marissa M. Alejandria
The aim of this study was to determine the predictors of mortality and describe laboratory trends among adults with confirmed COVID-19. The medical records of adult patients admitted to a referral hospital with COVID-19 were retrospectively reviewed. Demographic and clinical characteristics, and laboratory parameters, were compared between survivors and non-survivors. Predictors of mortality were determined by multivariate analysis. Mean laboratory values were plotted across illness duration. Of 1215 patients, 203 (16.7%) had mild, 488 (40.2%) moderate, 183 (15.1%) severe, and 341 (28.1%) critical COVID-19 on admission. In-hospital mortality was 18.2% (0% mild, 6.1% moderate, 15.8% severe, 47.5% critical). Predictors of mortality were age ≥ 60 years, COPD, qSOFA score ≥ 2, WBC > 10 × 109/L, absolute lymphocyte count < 1000, neutrophil ≥ 70%, PaO2/FiO2 ratio ≤ 200, eGFR < 90 mL/min/1.73 m2, LDH > 600 U/L, and CRP > 12 mg/L. Non-survivors exhibited an increase in LDH and decreases in PaO2/FiO2 ratio and eGFR during the 2nd–3rd week of illness. The overall mortality rate was high. Predictors of mortality were similar to those of other reports globally. Marked inflammation and worsening pulmonary and renal function were evident among non-survivors by the 2nd–3rd week of illness.